Reviews Ranolazine


No reviews yet.

Ranexa Drug Description
Ranexa
(ranolazine) Extended-Release Tablets
DRUG DESCRIPTION



What are the possible side effects of ranolazine (Ranexa)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

feeling like you might pass out;
swelling in your hands, ankles, or feet;
slow, fast, or pounding heartbeats;
tremors or shaking;
blood in your urine;
urinating less than usual or not at all;
...
Read All Potential Side Effects for Ranexa »




Ranexa (ranolazine) is available as a film-coated, non-scored, extended-release
tablet for oral administration.
Ranolazine is a racemic mixture, chemically described as 1-piperazineacetamide,
N-(2,6dimethylphenyl)- 4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-, (±)-.
It has an empirical formula of C24H33N3O4,
a molecular weight of 427.54 g/mole, and the following structural formula:








Ranolazine is a white to off-white solid. Ranolazine is soluble in dichloromethane and methanol; sparingly soluble in tetrahydrofuran, ethanol, acetonitrile, and acetone; slightly soluble in ethyl acetate, isopropanol, toluene, and ethyl ether; and very slightly soluble in water.
Ranexa tablets contain 500 mg or 1000 mg of ranolazine and the following inactive ingredients: carnauba wax, hypromellose, magnesium stearate, methacrylic acid copolymer (Type C), microcrystalline cellulose, polyethylene glycol, sodium hydroxide, and titanium dioxide. Additional inactive ingredients for the 500 mg tablet include polysorbate 80 and FD&C Yellow No. 6 Lake; additional inactive ingredients for the 1000 mg tablet include lactose monohydrate, triacetin, and Iron Oxide Yellow.
Last reviewed on RxList: 12/29/2008




Ranexa Drug Description
Ranexa
(ranolazine) Extended-Release Tablets
DRUG DESCRIPTION



What are the possible side effects of ranolazine (Ranexa)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

feeling like you might pass out;
swelling in your hands, ankles, or feet;
slow, fast, or pounding heartbeats;
tremors or shaking;
blood in your urine;
urinating less than usual or not at all;
...
Read All Potential Side Effects for Ranexa »




Ranexa (ranolazine) is available as a film-coated, non-scored, extended-release
tablet for oral administration.
Ranolazine is a racemic mixture, chemically described as 1-piperazineacetamide,
N-(2,6dimethylphenyl)- 4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-, (±)-.
It has an empirical formula of C24H33N3O4,
a molecular weight of 427.54 g/mole, and the following structural formula:








Ranolazine is a white to off-white solid. Ranolazine is soluble in dichloromethane and methanol; sparingly soluble in tetrahydrofuran, ethanol, acetonitrile, and acetone; slightly soluble in ethyl acetate, isopropanol, toluene, and ethyl ether; and very slightly soluble in water.
Ranexa tablets contain 500 mg or 1000 mg of ranolazine and the following inactive ingredients: carnauba wax, hypromellose, magnesium stearate, methacrylic acid copolymer (Type C), microcrystalline cellulose, polyethylene glycol, sodium hydroxide, and titanium dioxide. Additional inactive ingredients for the 500 mg tablet include polysorbate 80 and FD&C Yellow No. 6 Lake; additional inactive ingredients for the 1000 mg tablet include lactose monohydrate, triacetin, and Iron Oxide Yellow.
Last reviewed on RxList: 12/29/2008




Ranexa Drug Description
Ranexa
(ranolazine) Extended-Release Tablets
DRUG DESCRIPTION



What are the possible side effects of ranolazine (Ranexa)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

feeling like you might pass out;
swelling in your hands, ankles, or feet;
slow, fast, or pounding heartbeats;
tremors or shaking;
blood in your urine;
urinating less than usual or not at all;
...
Read All Potential Side Effects for Ranexa »




Ranexa (ranolazine) is available as a film-coated, non-scored, extended-release
tablet for oral administration.
Ranolazine is a racemic mixture, chemically described as 1-piperazineacetamide,
N-(2,6dimethylphenyl)- 4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-, (±)-.
It has an empirical formula of C24H33N3O4,
a molecular weight of 427.54 g/mole, and the following structural formula:








Ranolazine is a white to off-white solid. Ranolazine is soluble in dichloromethane and methanol; sparingly soluble in tetrahydrofuran, ethanol, acetonitrile, and acetone; slightly soluble in ethyl acetate, isopropanol, toluene, and ethyl ether; and very slightly soluble in water.
Ranexa tablets contain 500 mg or 1000 mg of ranolazine and the following inactive ingredients: carnauba wax, hypromellose, magnesium stearate, methacrylic acid copolymer (Type C), microcrystalline cellulose, polyethylene glycol, sodium hydroxide, and titanium dioxide. Additional inactive ingredients for the 500 mg tablet include polysorbate 80 and FD&C Yellow No. 6 Lake; additional inactive ingredients for the 1000 mg tablet include lactose monohydrate, triacetin, and Iron Oxide Yellow.
Last reviewed on RxList: 12/29/2008




Ranexa Drug Description
Ranexa
(ranolazine) Extended-Release Tablets
DRUG DESCRIPTION



What are the possible side effects of ranolazine (Ranexa)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

feeling like you might pass out;
swelling in your hands, ankles, or feet;
slow, fast, or pounding heartbeats;
tremors or shaking;
blood in your urine;
urinating less than usual or not at all;
...
Read All Potential Side Effects for Ranexa »




Ranexa (ranolazine) is available as a film-coated, non-scored, extended-release
tablet for oral administration.
Ranolazine is a racemic mixture, chemically described as 1-piperazineacetamide,
N-(2,6dimethylphenyl)- 4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-, (±)-.
It has an empirical formula of C24H33N3O4,
a molecular weight of 427.54 g/mole, and the following structural formula:








Ranolazine is a white to off-white solid. Ranolazine is soluble in dichloromethane and methanol; sparingly soluble in tetrahydrofuran, ethanol, acetonitrile, and acetone; slightly soluble in ethyl acetate, isopropanol, toluene, and ethyl ether; and very slightly soluble in water.
Ranexa tablets contain 500 mg or 1000 mg of ranolazine and the following inactive ingredients: carnauba wax, hypromellose, magnesium stearate, methacrylic acid copolymer (Type C), microcrystalline cellulose, polyethylene glycol, sodium hydroxide, and titanium dioxide. Additional inactive ingredients for the 500 mg tablet include polysorbate 80 and FD&C Yellow No. 6 Lake; additional inactive ingredients for the 1000 mg tablet include lactose monohydrate, triacetin, and Iron Oxide Yellow.
Last reviewed on RxList: 12/29/2008




Ranexa Drug Description
Ranexa
(ranolazine) Extended-Release Tablets
DRUG DESCRIPTION



What are the possible side effects of ranolazine (Ranexa)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

feeling like you might pass out;
swelling in your hands, ankles, or feet;
slow, fast, or pounding heartbeats;
tremors or shaking;
blood in your urine;
urinating less than usual or not at all;
...
Read All Potential Side Effects for Ranexa »




Ranexa (ranolazine) is available as a film-coated, non-scored, extended-release
tablet for oral administration.
Ranolazine is a racemic mixture, chemically described as 1-piperazineacetamide,
N-(2,6dimethylphenyl)- 4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-, (±)-.
It has an empirical formula of C24H33N3O4,
a molecular weight of 427.54 g/mole, and the following structural formula:








Ranolazine is a white to off-white solid. Ranolazine is soluble in dichloromethane and methanol; sparingly soluble in tetrahydrofuran, ethanol, acetonitrile, and acetone; slightly soluble in ethyl acetate, isopropanol, toluene, and ethyl ether; and very slightly soluble in water.
Ranexa tablets contain 500 mg or 1000 mg of ranolazine and the following inactive ingredients: carnauba wax, hypromellose, magnesium stearate, methacrylic acid copolymer (Type C), microcrystalline cellulose, polyethylene glycol, sodium hydroxide, and titanium dioxide. Additional inactive ingredients for the 500 mg tablet include polysorbate 80 and FD&C Yellow No. 6 Lake; additional inactive ingredients for the 1000 mg tablet include lactose monohydrate, triacetin, and Iron Oxide Yellow.
Last reviewed on RxList: 12/29/2008





Other reviews about Ranolazine on wordpress

Angina Therapy Approved
  by Mike
Jan 30 2006. CV Therapeutics announced Friday that it has received approval to market ranolazine in the United States as part of a combination regimen for the treatment […]


After Hours
  by misstrade
18:07 TFCO Tufco Technologies reports Q4 EPS of $0.11 vs $0.01 yr ago; revs rise 24.0% to $35.3 mln (6.20 -0.20) 18:05 DVR Cal Dive files […]


Ranolazine receives EU marketing authorization for Chronic Angina
  by crimsoncanary
CV Therapeutics have announced that the EMEA has granted approval for ranolazine in the treatment of patients with chronic angina in all 27 European Union (EU) member states. […]


CV therapeutics announce FDA is continuing review of Ranexa for Angina
  by crimsoncanary
CV Therapeutics have announced that the FDA is continuing its review of Ranexa (ranolazine extended-release tablets) even though the PDUFA action date of July 27, 2008 has been […]


Ranolazine For Angina Treatment
  by healtherm2
Ranolazine, a new treatment for chronic, stable angina, is discussed as a safe and effective option for patients in a New Drug Class paper released on October […]


LANOXIN® (digoxin injection 500 mcg (0.5 mg) in 2 mL (250 mcg [0.25 mg] per mL))
  by kanlayanee
[caption id="" align="alignnone" width="288" caption=" LANOXIN 125 MCG TABLET"][/caption] Adult Min/Max Dose: 2.5mcg/kg/20.0mcg/kg Pediatric Min/Max Dose: 7.0mcg/kg/20.0mcg/kg Common Dosages by Indication: Chronic Heart Failure take 1 tablet (125 mcg) by oral route […]


Levaquin® (levofloxacin)
  by kanlayanee
[caption id="" align="alignnone" width="288" caption=" LEVAQUIN 250 MG TABLET"][/caption] Iquix®, Levaquin®, Quixin, Quixinâ„¢ Adult Min/Max Dose: 200.0mg/750.0mg Pediatric Min/Max Dose: 5.0mg/kg/10.0mg/kg WARNING Fluoroquinolones, including LEVAQUIN®, are associated with an increased risk […]


Astellas launches hostile takeover for CV Therapeutics
  by Larry Husten
Astellas Pharma announced today that it was launching a hostile takeover for CV Therapeutics, the company that manufactures ranolazine (Ranexa) and regadenoson (Lexiscan).   As we reported back […]


Gilead, topping Astellas, to acquire CV Therapeutics
  by Larry Husten
Gilead Sciences will acquire CV Therapeutics, makers of ranolazine (Ranexa) and regadenoson (Lexiscan). The announcement comes on the heels of Astella's hostile attempt to acquire CV Therapeutics, as […]


13 Drugs on Latest FDA List for Safety Monitoring
  by zedie
A watch list of 13 drugs based on potential signs of serious risks or new safety information collected by the Adverse Event Reporting System (AERS) of the US […]



Other reviews about Ranolazine on web:

Ranolazine, sold under the trade name Ranexa by Gilead Sciences (who acquired the developer, CV Therapeutics in 2009), is an antianginal medication. Ranolazine - Wikipedia, the free encyclopedia


All about Ranolazine. View complete and up to date Ranolazine information - part of the Drugs.com trusted medication database. Ranolazine Facts and Comparisons at Drugs.com


Ranolazine Brand names: Ranexa® Chemical formula: Drug Forms: Ranolazine extended-release tablets (below) Ranolazine Oral tablet, Ranolazine: Information from Answers.com


Physician reviewed ranolazine patient information - includes ranolazine description, dosage and directions. ranolazine medical facts from Drugs.com


Ranolazine is a prescription drug used for the treatment of chronic angina (chest pain associated with heart disease). It should only be used in people who have not achieved an ... Ranolazine - Medpedia


Learn about the prescription medication Ranexa (Ranolazine), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Ranexa (Ranolazine) Drug Information: Uses, Side Effects, Drug ...


Pronunciation: ra NOE la zeen Brand: Ranexa What is the most important information I should know about ranolazine? /EF/1813AC397E8E4DE9587B4FC913760.g ranolazine - MSN Health & Fitness - Medications


ranolazine, an antianginal. indications This drug is used in combination with other antianginals (such as amlodipine, beta-blockers, or nitrates) to treat chronic stable angina ... ranolazine - definition of ranolazine in the Medical dictionary ...


Ranexa (ranolazine extended-release tablets) is a prescription medication used to treat adults with chronic angina. Ranexa.com – Ranexa (ranolazine extended-release tablets ...


Why It Is Prescribed. Ranolazine is used with other medications to treat angina (chest pain or pressure that is felt when the heart does not get enough oxygen) that is a symptom of ... Ranolazine - Kosmix : Reference, Videos, Images, News, Shopping ...





Featured Reviews

Reviews Mexitil

Mexitil Drug Description MEXITIL (mexiletine hydrochloride) Capsule Capsules of 150 mg, 200 mg and 250 mg Oral Antiarrhythmic DRUG DESCRIPTION What are the possible side effects of mexiletine (Mexitil)? If you experience any...
Read More  |  Review This
Reviews Norethindrone and Ethinyl Estradiol

Brevicon Drug Description Brevicon® (norethindrone and ethinyl estradiol) Tablets USP, 0.5 mg/0.035 mg Norinyl® 1+35 (norethindrone and ethinyl estradiol) Tablets USP, 1 mg/0.035 mg Norinyl® 1+50 (norethindrone and...
Read More  |  Review This
Reviews Actiq

Actiq Drug Description ACTIQ® (fentanyl citrate) Oral Transmucosal Lozenge WARNING IMPORTANCE OF PROPER PATIENT SELECTION, DOSING, and POTENTIAL FOR ABUSE Reports of serious adverse events, including deaths in patients treated ...
Read More  |  Review This
Reviews Methysergide maleate

Sansert Drug Description Sansert® (methysergide maleate) tablets WARNING Retroperitoneal Fibrosis, Pleuropulmonary Fibrosis and Fibrotic Thickening of Cardiac Valves May Occur in Patients Receiving Long-term Methysergide Maleate Therapy....
Read More  |  Review This
Reviews Lidocaine and Tetracaine

Synera Drug Description Synera® (lidocaine 70 mg and tetracaine 70 mg) Topical Patch DRUG DESCRIPTION Synera® consists of a thin, uniform layer of a local anesthetic formulation with an integrated, oxygen-activated heating component...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....